Q3 2026 13F filing
Updated 9 days ago33 disclosed positions worth $589.2M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | B BIOMARIN PHARMACEUTICAL INC | $70.3M | 1.17M | 11.93% | — |
| 2 | B BIOCRYST PHARMACEUTICALS INC | $59M | 7.08M | 10.01% | — |
| 3 | T TRAVERE THERAPEUTICS INC | $56.5M | 959.6K | 9.59% | — |
| 4 | I INDIVIOR PHARMACEUTICALS INC | $54.7M | 1.53M | 9.29% | — |
| 5 | P PHARVARIS N V | $31.3M | 987.6K | 5.32% | — |
| 6 | C CELCUITY INC | $30.4M | 382.9K | 5.17% | — |
| 7 | I IONIS PHARMACEUTICALS INC | $26.8M | 599.8K | 4.55% | — |
| 8 | S SUPERNUS PHARMACEUTICALS | $25.9M | 601.7K | 4.40% | — |
| 9 | N NUVATION BIO INC | $25.1M | 4.49M | 4.26% | — |
| 10 | V VERA THERAPEUTICS INC | $21.1M | 652.2K | 3.57% | — |
| 11 | T TREVI THERAPEUTICS INC | $20.7M | 1.45M | 3.52% | — |
| 12 | B BICARA THERAPEUTICS INC | $19.8M | 1.06M | 3.36% | — |
| 13 | R RELMADA THERAPEUTICS INC | $19.7M | 5.24M | 3.35% | — |
| 14 | A ABIVAX SA | $14.1M | 142.6K | 2.40% | — |
| 15 | A ACLARIS THERAPEUTICS INC | $13.2M | 2.50M | 2.24% | — |
| 16 | I INSMED INC | $12.2M | 106.5K | 2.06% | — |
| 17 | N NEUROCRINE BIOSCIENCES INC | $11.8M | 83.4K | 2.01% | — |
| 18 | I IMMUNOCORE HLDGS PLC | $11.6M | 384.3K | 1.98% | — |
| 19 | E ERASCA INC | $8.9M | 610.1K | 1.52% | — |
| 20 | C CAPRICOR THERAPEUTICS INC | $8.5M | 892.5K | 1.43% | — |
| 21 | D DIANTHUS THERAPEUTICS INC | $7M | 80.0K | 1.20% | — |
| 22 | N NEUROGENE INC | $6.1M | 217.7K | 1.03% | — |
| 23 | C CORBUS PHARMACEUTICALS HLDGS | $6M | 886.4K | 1.03% | — |
| 24 | T TONIX PHARMACEUTICALS HLDG C | $5.5M | 563.7K | 0.93% | — |
| 25 | S SAGIMET BIOSCIENCES INC | $5M | 502.6K | 0.84% | — |
| 26 | D DYNE THERAPEUTICS INC | $4.8M | 300.9K | 0.82% | — |
| 27 | A AVALYN PHARMACEUTICALS INC | $3.6M | 126.7K | 0.61% | — |
| 28 | ? N/A ATTOVIA THERAPEUTICS INC | $3.1M | 182.3K | 0.53% | — |
| 29 | P PHATHOM PHARMACEUTICALS INC | $2M | 276.8K | 0.34% | — |
| 30 | ? N/A LEXEO THERAPEUTICS INC | $2M | 593.7K | 0.34% | — |
| 31 | O OLEMA PHARMACEUTICALS INC | $1.8M | 206.4K | 0.30% | — |
| 32 | T TENAX THERAPEUTICS INC | $231K | 122.2K | 0.04% | — |
| 33 | A ALVOTECH | $155K | 26.7K | 0.03% | — |